Invesco Ltd. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2024. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$188,883
+23.0%
61,127
+2.7%
0.00%
Q1 2024$153,608
+8.4%
59,538
+5.1%
0.00%
Q4 2023$141,683
+23.3%
56,673
+0.1%
0.00%
Q3 2023$114,929
-6.7%
56,615
+5.7%
0.00%
Q2 2023$123,142
-13.4%
53,540
+14.0%
0.00%
Q1 2023$142,273
+34.6%
46,955
+3.5%
0.00%
Q4 2022$105,686
+46.8%
45,359
+19.5%
0.00%
Q3 2022$72,000
-24.2%
37,965
+8.3%
0.00%
Q2 2022$95,000
+18.8%
35,040
+30.3%
0.00%
Q1 2022$80,000
-19.2%
26,898
+6.0%
0.00%
Q4 2021$99,000
-21.4%
25,385
-13.0%
0.00%
Q3 2021$126,000
+65.8%
29,180
+15.9%
0.00%
Q2 2021$76,000
-87.2%
25,186
-78.5%
0.00%
Q4 2017$592,000
-15.4%
117,321
+3.9%
0.00%
Q3 2017$700,000
+98.3%
112,927
+15.1%
0.00%
Q2 2017$353,000
+10.0%
98,090
-0.7%
0.00%
Q1 2017$321,00098,8000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2024
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders